De Pillis et al. [163] proposed a sophisticated model involves tumor cells and specific and non-specific immune cells (i.e., nature killer (NK) cells) and employs chemotherapy and two types of immunotherapy (IL-2 supplementation and CD8+ T cell infusion) as treatment modalities. The gene discussed is IL2; the disease is neoplasm.